AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 145 filers reported holding AGIOS PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 1.31 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $1,967,000 | +14.6% | 29,465 | -11.7% | 0.24% | +10.9% |
| Q2 2017 | $1,717,000 | -15.3% | 33,365 | -3.9% | 0.22% | -20.2% |
| Q1 2017 | $2,027,000 | +45.4% | 34,715 | +3.9% | 0.28% | +37.1% |
| Q4 2016 | $1,394,000 | -25.3% | 33,415 | -5.4% | 0.20% | -27.9% |
| Q3 2016 | $1,865,000 | +29.2% | 35,315 | +2.5% | 0.28% | +21.2% |
| Q2 2016 | $1,444,000 | +77.2% | 34,465 | +71.7% | 0.23% | +75.0% |
| Q1 2016 | $815,000 | +1.2% | 20,075 | +62.0% | 0.13% | +3.9% |
| Q4 2015 | $805,000 | -2.2% | 12,395 | +6.3% | 0.13% | -7.3% |
| Q3 2015 | $823,000 | -35.4% | 11,665 | +1.7% | 0.14% | -29.4% |
| Q2 2015 | $1,274,000 | +64.4% | 11,465 | +39.5% | 0.19% | +65.8% |
| Q1 2015 | $775,000 | +1.0% | 8,220 | +20.0% | 0.12% | -0.8% |
| Q4 2014 | $767,000 | – | 6,850 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Ventures 2007 General Partner LLC | 1,930,369 | $118,428,000 | 83.56% |
| Third Rock Ventures, LLC | 3,070,090 | $188,350,000 | 21.97% |
| Opaleye Management Inc. | 113,500 | $6,963,225,000 | 5.43% |
| BB BIOTECH AG | 1,890,521 | $115,983,000 | 4.72% |
| Eventide Asset Management | 431,600 | $26,479,000 | 3.70% |
| Atika Capital Management LLC | 54,000 | $3,313,000 | 2.55% |
| Cormorant Asset Management, LP | 100,000 | $6,135,000 | 1.26% |
| BRIDGER MANAGEMENT, LLC | 220,099 | $13,503,000 | 0.92% |
| Ghost Tree Capital, LLC | 20,000 | $1,227,000 | 0.67% |
| HAMILTON LANE ADVISORS LLC | 27,544 | $1,690,000 | 0.55% |